Consumer perceptions of generic drug substitution practices in the USA

Journal of Pharmacy Practice and Research

Volumn 34, Issue 4, 2004, Pages 262-266

  Sansgiry, Sujit S ^a   Bhosle, Monali J ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; VITAMIN;

ADULT; CLINICAL PRACTICE; CONSUMER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MALE; PERCEPTION; PHARMACIST; REVIEW; SOCIAL ASPECT; UNITED STATES;

EID: 13544263337     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2004344262     Document Type: Review

References (31)

1. Academy of Managed Care Pharmacy. Principles of a sound drug formulary system. Alexandria: Academy of Managed Care Pharmacy; 2000.
2. Yarnall W. Generic substitution: therapeutic equivalence and cost containment. Am Druggist 1994; 210: 59-68.
3. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: How well are states closing the gap? Health Aff 2002; w253-68.
4. Mills RJ, Bhandari S. Health insurance coverage in the United States: 2002. Washington DC: US Census Bureau; 2003. Available 〈www.census.gov/ prod/2003pubs/p60-223.pdf〉.
5. Christensen TP, Kirking DM, Ascione FJ, Welage LG, Gaither CA. Drug product selection: legal issues. J Am Pharm Assoc 2001; 41: 868-74.
6. Smeaton J. The generics market. Aust J Pharm 2000; 81: 540-2.
7. Burton K, Varghese J. The PBS and the Australia-US Free Trade Agreement. Canberra: Commonwealth of Australia; 2004. Available 〈www.aph.gov.au/ library/ pubs/RN/2004-05/05rn03.pdf〉.
8. Rickard M. How much will the PBS cost? Canberra: Commonwealth of Australia; 2004. Available 〈www.aph.gov.au/library/pubs/rn/2003-04/04rn29. pdf〉.
9. Burton B. Changing prescription software to favour generics could save Australia 40m pound sterling a year. BMJ 2003; 326: 184.
10. Lockney A. Generic medicines. inPHARMation (Pharmaceutical Society of Australia) 2003; 4: 6-10.
11. Hassali A, Stewart K, Kong D. Quality use of generic medicine [editorial]. Aust Prescr 2004; 27: 80-1.
12. Kreling DH, Mott DA, Wiederholt JB, Lundy J, Levitt L. Prescription drug trends: a chartbook update. Menlo Park: Henry J Kaiser Family Foundation; 2001.
13. Express Scripts Inc. Drug trend report 2003: featuring the pharmacy benefit guide. Maryland Heights: Express Scripts Inc; 2004. Available 〈www.expressscripts.com/ourcompany/news/industryreports/drugtrendreport/ 2003/toe.htm〉.
14. Despite favorable views toward generic drugs, drug costs higher than ever. Washington DC: Business Wire; 1999. Available 〈www.findarticles.com/ cf_dls/ m0EIN/1999_Sept_27/55863481/print.jhtml〉.
15. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers' views on generic medications. J Am Pharm Assoc 2001; 41: 729-36.
16. Nair KV. Do consumer attitudes predict prescription purchasing behavior? Manag Care Interface 2003; 16: 22-7.
17. Guberman A, Corman C. Generic substitution for brand name antiepileptic drugs; a survey. Can J Neurol Sci 2000; 27: 37-43.
18. Yelkur R, Capella LM. Generic prescription drugs: awareness, attitudes and intentions of elderly consumers. Marketing: foundations of a changing world. Southern Marketing Association 1995: 57-60.
19. Wolfgang AP, Perri M. Older adults and generic drugs: an analysis of attitudes and intentions. J Pharm Mark Manage 1991; 5: 87-99.
20. Shepherd MD. Investigations into consumer perceptions of generic drug products as it relates to enhancing generic drug product marketing. Austin: University of Texas; 1988.
21. Caroll NV, Wolfgang AP, Kotzan JA, Perri M. Consumers' attitudes and actions toward generic drugs. J Pharm Mark Manage 1988; 2: 87-99.
22. Tootelian, D, Geadeke RM, Schlacter J. Branded versus generic prescription drugs: perceptions of risk, efficacy, safety, and value. J Healthcare Mark 1988; 8: 26-9.
23. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000; 40: 378-83.
24. Momani M, Odedina F, Rosenbluth S, Madhavan S. Drug-management strategies: consumers' perspectives. J Managed Care Pharm 2000; 6: 122-8.
25. Grahn JL. Relationship of consumers' perceptions of drugs to drug use. Public Health Rep 1983; 98: 85-90.
26. Kerlinger FN, Lee HB. Foundations of behavioral research. 5th ed. Orlando: Earl McPeek, Harcourt Inc; 2000. p. 641-63.
27. Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40: 662-74.
28. Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci 1999; 21: 260-5.
29. Toivianen H, Vuorenkoski L, Hemminki E. Finnish physicians show little support for consumer advertising of prescription drugs. N Z Med J 2004; 117: U907.
30. FDA Center for Drug Evaluation and Research. Brief summary: disclosing risk information in consumer-directed print advertisements. Rockville: FDA; 2004. Available 〈www.fda.gov/cder/guidance/5669dft.doc〉.
31. FDA Center for Drug Evaluation and Research. Savings from generic drugs purchased at retail pharmacies. Rockville: FDA; 2004. Available 〈www.fda.gov/ cder/consumerinfo/savingsfromgenericdrugs.htm〉.